The role of 15-lipoxygenase-l expression and its potential role in the pathogenesis of endometrial hyperplasia and endometrial adenocarcinomas

M. E. Sak, I. Alanbay, Ana Rodriguez, T. Gokaslan, M. Borahay, I. Shureiqi, Gokhan Kilic

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Purpose of Investigation: To investigate the presence of 15-lipoxygenase-1 (15-LOX-1) expression and its potential role in the pathogenesis of endometrial hyperplasia and endometrial adenocarcinomas. Materials and Methods: The authors investigated the presence of 15-LOX-l expression in samples from patients diagnosed with normal endometrium (n = 12), endometrial hyperplasia (n = 12), and endometrial cancer (n = 12). The immunohistochemical stainings were scored by three independent pathologists. A Western blot of 15-LOX-l determined the presence of protein expression in normal endometrium. A Kolmogorov-Smimov test was used to evaluate the data's distribution pattern. For pairwise comparisons of the combined scores between groups, the Mann-Whitney U test was used. Results: Based on the combined scores for 15-LOX-l expression, strong immunochemistry staining was observed in samples diagnosed with normal endometrium. There was a significant difference in 15-LOX-l expression between normal endometrium and endometrial adenocarcinoma (p = 0.03). Comparing tissues from normal endometrium and endometrial hyperplasia, there was a decline in the expression from normal endometrium to endometrial hyperplasia. However, the difference was not statistically significant. Conclusion: The present results show that a decrease of 15-LOX-l expression in the endometrial tumorigenesis process, starting from normal endometrium to hyperplasia and endometrial cancer, might be a trigger. Further studies are required to determine its potential use as a marker in a larger randomized multicenter study.

Original languageEnglish (US)
Pages (from-to)36-40
Number of pages5
JournalEuropean Journal of Gynaecological Oncology
Volume37
Issue number1
DOIs
StatePublished - 2016

Fingerprint

Arachidonate 15-Lipoxygenase
Endometrial Hyperplasia
Endometrium
Adenocarcinoma
Endometrial Neoplasms
Staining and Labeling
Immunochemistry
Lipoxygenase
Nonparametric Statistics
Multicenter Studies
Hyperplasia
Carcinogenesis
Western Blotting

Keywords

  • 15-LOX-1, endometrial hyperplasia
  • Endometrial adenocarcinomas

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

The role of 15-lipoxygenase-l expression and its potential role in the pathogenesis of endometrial hyperplasia and endometrial adenocarcinomas. / Sak, M. E.; Alanbay, I.; Rodriguez, Ana; Gokaslan, T.; Borahay, M.; Shureiqi, I.; Kilic, Gokhan.

In: European Journal of Gynaecological Oncology, Vol. 37, No. 1, 2016, p. 36-40.

Research output: Contribution to journalArticle

@article{1d11f8d311764a248317af71018d9c2c,
title = "The role of 15-lipoxygenase-l expression and its potential role in the pathogenesis of endometrial hyperplasia and endometrial adenocarcinomas",
abstract = "Purpose of Investigation: To investigate the presence of 15-lipoxygenase-1 (15-LOX-1) expression and its potential role in the pathogenesis of endometrial hyperplasia and endometrial adenocarcinomas. Materials and Methods: The authors investigated the presence of 15-LOX-l expression in samples from patients diagnosed with normal endometrium (n = 12), endometrial hyperplasia (n = 12), and endometrial cancer (n = 12). The immunohistochemical stainings were scored by three independent pathologists. A Western blot of 15-LOX-l determined the presence of protein expression in normal endometrium. A Kolmogorov-Smimov test was used to evaluate the data's distribution pattern. For pairwise comparisons of the combined scores between groups, the Mann-Whitney U test was used. Results: Based on the combined scores for 15-LOX-l expression, strong immunochemistry staining was observed in samples diagnosed with normal endometrium. There was a significant difference in 15-LOX-l expression between normal endometrium and endometrial adenocarcinoma (p = 0.03). Comparing tissues from normal endometrium and endometrial hyperplasia, there was a decline in the expression from normal endometrium to endometrial hyperplasia. However, the difference was not statistically significant. Conclusion: The present results show that a decrease of 15-LOX-l expression in the endometrial tumorigenesis process, starting from normal endometrium to hyperplasia and endometrial cancer, might be a trigger. Further studies are required to determine its potential use as a marker in a larger randomized multicenter study.",
keywords = "15-LOX-1, endometrial hyperplasia, Endometrial adenocarcinomas",
author = "Sak, {M. E.} and I. Alanbay and Ana Rodriguez and T. Gokaslan and M. Borahay and I. Shureiqi and Gokhan Kilic",
year = "2016",
doi = "10.12892/ejgo30I7.2016",
language = "English (US)",
volume = "37",
pages = "36--40",
journal = "European Journal of Gynaecological Oncology",
issn = "0392-2936",
publisher = "S.O.G. CANADA Inc.",
number = "1",

}

TY - JOUR

T1 - The role of 15-lipoxygenase-l expression and its potential role in the pathogenesis of endometrial hyperplasia and endometrial adenocarcinomas

AU - Sak, M. E.

AU - Alanbay, I.

AU - Rodriguez, Ana

AU - Gokaslan, T.

AU - Borahay, M.

AU - Shureiqi, I.

AU - Kilic, Gokhan

PY - 2016

Y1 - 2016

N2 - Purpose of Investigation: To investigate the presence of 15-lipoxygenase-1 (15-LOX-1) expression and its potential role in the pathogenesis of endometrial hyperplasia and endometrial adenocarcinomas. Materials and Methods: The authors investigated the presence of 15-LOX-l expression in samples from patients diagnosed with normal endometrium (n = 12), endometrial hyperplasia (n = 12), and endometrial cancer (n = 12). The immunohistochemical stainings were scored by three independent pathologists. A Western blot of 15-LOX-l determined the presence of protein expression in normal endometrium. A Kolmogorov-Smimov test was used to evaluate the data's distribution pattern. For pairwise comparisons of the combined scores between groups, the Mann-Whitney U test was used. Results: Based on the combined scores for 15-LOX-l expression, strong immunochemistry staining was observed in samples diagnosed with normal endometrium. There was a significant difference in 15-LOX-l expression between normal endometrium and endometrial adenocarcinoma (p = 0.03). Comparing tissues from normal endometrium and endometrial hyperplasia, there was a decline in the expression from normal endometrium to endometrial hyperplasia. However, the difference was not statistically significant. Conclusion: The present results show that a decrease of 15-LOX-l expression in the endometrial tumorigenesis process, starting from normal endometrium to hyperplasia and endometrial cancer, might be a trigger. Further studies are required to determine its potential use as a marker in a larger randomized multicenter study.

AB - Purpose of Investigation: To investigate the presence of 15-lipoxygenase-1 (15-LOX-1) expression and its potential role in the pathogenesis of endometrial hyperplasia and endometrial adenocarcinomas. Materials and Methods: The authors investigated the presence of 15-LOX-l expression in samples from patients diagnosed with normal endometrium (n = 12), endometrial hyperplasia (n = 12), and endometrial cancer (n = 12). The immunohistochemical stainings were scored by three independent pathologists. A Western blot of 15-LOX-l determined the presence of protein expression in normal endometrium. A Kolmogorov-Smimov test was used to evaluate the data's distribution pattern. For pairwise comparisons of the combined scores between groups, the Mann-Whitney U test was used. Results: Based on the combined scores for 15-LOX-l expression, strong immunochemistry staining was observed in samples diagnosed with normal endometrium. There was a significant difference in 15-LOX-l expression between normal endometrium and endometrial adenocarcinoma (p = 0.03). Comparing tissues from normal endometrium and endometrial hyperplasia, there was a decline in the expression from normal endometrium to endometrial hyperplasia. However, the difference was not statistically significant. Conclusion: The present results show that a decrease of 15-LOX-l expression in the endometrial tumorigenesis process, starting from normal endometrium to hyperplasia and endometrial cancer, might be a trigger. Further studies are required to determine its potential use as a marker in a larger randomized multicenter study.

KW - 15-LOX-1, endometrial hyperplasia

KW - Endometrial adenocarcinomas

UR - http://www.scopus.com/inward/record.url?scp=84960853531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960853531&partnerID=8YFLogxK

U2 - 10.12892/ejgo30I7.2016

DO - 10.12892/ejgo30I7.2016

M3 - Article

VL - 37

SP - 36

EP - 40

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

SN - 0392-2936

IS - 1

ER -